XML 38 R25.htm IDEA: XBRL DOCUMENT v3.8.0.1
Xcede Technologies, Inc. Joint Venture (Details Textual) - USD ($)
1 Months Ended 3 Months Ended
Nov. 30, 2016
Nov. 18, 2016
Dec. 31, 2017
Dec. 31, 2016
Debt Conversion, Original Debt, Amount   $ 5,500,000    
Gain (Loss) on Extinguishment of Debt   $ 1,900,000    
Noncontrolling Interest [Member]        
Debt Conversion, Original Debt, Amount $ 3,100,000      
Debt Conversion, Converted Instrument, Shares Issued 3,055,551      
Gain (Loss) on Extinguishment of Debt     $ 300,000  
Xcede Technologies inc [Member]        
Debt Instrument, Interest Rate, Stated Percentage 5.00%      
Committed Investment In Cash $ 1,200,000      
Debt Conversion, Converted Instrument, Shares Issued 5,394,120      
Capital Stock Financing Discount Percentage 20.00%      
Noncontrolling Interest, Ownership Percentage by Parent   59.00% 62.00%  
Noncontrolling Interest, Description     Noncontrolling interest represents the value of the Series A Preferred and common stock not owned by DBM plus 17% of cumulative losses of Xcede based on the 17% common stock ownership held by noncontrolling interests.  
Dynasil Biomedical [Member]        
Debt Conversion, Original Debt, Amount $ 2,400,000      
Debt Conversion, Converted Instrument, Shares Issued 2,338,569      
Gain (Loss) on Extinguishment of Debt     $ 1,600,000  
External Funding [Member] | Convertible Debt [Member]        
Debt Conversion, Original Debt, Amount $ 5,200,000      
Secured Promissory Note [Member] | Xcede Technologies inc [Member]        
Debt Instrument, Interest Rate, Stated Percentage 2.00%      
Debt Instrument, Maturity Date Dec. 31, 2025      
Notes Payable $ 1,500,000      
Proceeds from Notes Payable $ 500,000      
Expense Recognized In Long Term Contract     $ 163,000 $ 38,000
Imputed Interest Rate     5.40%  
Series B Preferred Stock [Member]        
Preferred Stock, Liquidation Preference Per Share     $ 1.27  
Preferred Stock, Liquidation Preference, Value     $ 1,100,000  
Series B Preferred Stock [Member] | Xcede Technologies inc [Member]        
Proceeds from Notes Payable     2,016,000,000  
Series A Preferred Stock [Member]        
Debt Conversion, Converted Instrument, Amount     $ 3,600,000  
Preferred Stock, Liquidation Preference Per Share     $ 1.016  
Preferred Stock, Liquidation Preference, Value     $ 5,500,000  
Series A Preferred Stock [Member] | Noncontrolling Shareholders [Member]        
Preferred Stock, Liquidation Preference, Value     3,100,000  
Series A Preferred Stock [Member] | Dynasil Biomedical [Member]        
Preferred Stock, Liquidation Preference, Value     $ 2,400,000